Phorest, an Ireland-based salon software company, launched its U.S. headquarters on Thursday (August 15) in Philadelphia, and plans to have at least 30 employees by the year’s end, nearly doubling its U.S. presence.

Irish Chamber Member, Joe Burke (pictured below), Deputy Secretary, PA Department of Community & Economic Development, Office of International Business Development, discussed the State’s role in attracting and supporting foreign direct investment into the Pennsylvania.

Read more at PhiladelphiaInquirer.com.

Click below read more on Technical.ly Philly.

An Irish salon software company is putting down roots in Philly

Almac Group’s Position Remains Unchallenged in Ulster Business Top 100 Listings

Craigavon, N.I., 07 Aug 2019Almac Group, the global contract pharmaceutical development and manufacturing organization, is privileged to be included in the top ten list of “Ulster Business Top 100 companies” for the second consecutive year.

The news comes as the Group’s figures for year ending 30 September 2018 reported a £17 million rise in revenue at £548 million with pre-tax profits recorded at £27 million. Read More

Recently the marketing team of Dublin Airport Central, which is Ireland’s largest commercial office development, reached out to Irish Chamber to share news of their newest development. They are building 300,000 sqm of Grade A, LEED Gold office space, located just 50m from Terminal 2 at Dublin Airport — 40,000 sqm, of which will be delivered over the next 2 years.

Read More

Almac Group Launches Almac Adapt™ – a New Patient-Centric Supply Solution

Innovative Just in Time Manufacturing (JTM) enables sponsors full late stage customisation of their clinical trial materials

Craigavon, N.I., 13 June 2019Almac Clinical Services, part of the Almac Group, has today announced the launch of Almac Adapt™ – an innovative Just in Time Manufacturing (JTM) solution.  This latest offering puts patients first and provides sponsors with a unique, adaptive supply strategy to ultimately meet the expanding challenges of clinical trials.
Read More

Almac Group Reports Further Growth During Period of Significant Global Expansion

2017-18 figures record turnover increased by £17 million with 8% growth in global workforce

Craigavon, N.I., 03 Jun 2019 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, has reported a £17 million rise in turnover from £531 million to £548 million for 2017-18.  Pre-tax profits were recorded at £27 million whilst average employee figures increased by 8% from 4,407 to 4,798 for the same period. The figures were recorded in Almac’s annual report with its results for the year ending 30 September 2018.
Read More